Find VLX-1005 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ml355, 1532593-30-8, Ml355 free base, Ml-355, Vlx-1005, Jku4xcc48y
Molecular Formula
C21H19N3O4S2
Molecular Weight
441.5  g/mol
InChI Key
OWHBVKBNNRYMIN-UHFFFAOYSA-N
FDA UNII
JKU4XCC48Y

VLX-1005
1 2D Structure

VLX-1005

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide
2.1.2 InChI
InChI=1S/C21H19N3O4S2/c1-28-18-7-4-5-14(20(18)25)13-22-15-9-11-16(12-10-15)30(26,27)24-21-23-17-6-2-3-8-19(17)29-21/h2-12,22,25H,13H2,1H3,(H,23,24)
2.1.3 InChI Key
OWHBVKBNNRYMIN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC1=CC=CC(=C1O)CNC2=CC=C(C=C2)S(=O)(=O)NC3=NC4=CC=CC=C4S3
2.2 Other Identifiers
2.2.1 UNII
JKU4XCC48Y
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ml355

2. N-(1,3-benzothiazol-2-yl)-4-((2-hydroxy-3-methoxyphenyl)methylamino)benzenesulfonamide

2.3.2 Depositor-Supplied Synonyms

1. Ml355

2. 1532593-30-8

3. Ml355 Free Base

4. Ml-355

5. Vlx-1005

6. Jku4xcc48y

7. Chembl3113165

8. N-(benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide

9. Benzenesulfonamide, N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)-

10. N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)benzenesulfonamide

11. N-2-benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]-benzenesulfonamide

12. Ncgc00263773-03

13. N-2-benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]benzenesulfonamide

14. Unii-jku4xcc48y

15. Gtpl8752

16. Schembl16646023

17. Bcp28954

18. Ex-a1987

19. Bdbm50447175

20. Ml 355

21. S6557

22. Ml 355;ml-355

23. Zinc103266485

24. Cs-3351

25. Ncgc00263773-01

26. Ncgc00263773-18

27. Ac-36858

28. Bs-15552

29. Hy-12341

30. B8014

31. A908037

32. Q27087172

33. N-(2-benzothiazolyl)-4-(2-hydroxy-3-methoxybenzylamino)benzenesulfonamide

34. N-(benzo[d]thiazol-2-yl)-4-(2-hydroxy-3-methoxybenzylamino)benzenesulfonamide

35. Ml-355; Ml-355;n-(benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide

2.4 Create Date
2013-02-22
3 Chemical and Physical Properties
Molecular Weight 441.5 g/mol
Molecular Formula C21H19N3O4S2
XLogP34.3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count7
Exact Mass441.08169844 g/mol
Monoisotopic Mass441.08169844 g/mol
Topological Polar Surface Area137 Ų
Heavy Atom Count30
Formal Charge0
Complexity651
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty